| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.
|
BMC Infect Dis
|
2009
|
1.36
|
|
2
|
Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot.
|
Diabetes Care
|
2009
|
1.32
|
|
3
|
1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes.
|
Cytokine
|
2009
|
1.20
|
|
4
|
Downregulation of CD40 ligand response in monocytes from sepsis patients.
|
Clin Vaccine Immunol
|
2008
|
1.20
|
|
5
|
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
|
J Med Chem
|
2005
|
1.08
|
|
6
|
Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigation.
|
J Med Chem
|
2005
|
0.98
|
|
7
|
Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy.
|
AJR Am J Roentgenol
|
2008
|
0.86
|
|
8
|
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.
|
J Med Chem
|
2006
|
0.83
|
|
9
|
Vitamin D3 modulates T lymphocyte responses in hepatitis C virus-infected liver transplant recipients.
|
Dig Liver Dis
|
2011
|
0.82
|
|
10
|
Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation.
|
Immunology
|
2007
|
0.82
|
|
11
|
Clinical analysis of human urine by means of potentiometric Electronic tongue.
|
Talanta
|
2008
|
0.81
|
|
12
|
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations.
|
J Med Chem
|
2009
|
0.79
|
|
13
|
Upregulation of the inhibitory receptor ILT4 in monocytes from septic patients.
|
Hum Immunol
|
2013
|
0.78
|
|
14
|
Serum soluble ST2 as diagnostic marker of systemic inflammatory reactive syndrome of bacterial etiology in children.
|
Pediatr Infect Dis J
|
2014
|
0.77
|
|
15
|
Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm.
|
Radiol Med
|
2013
|
0.77
|
|
16
|
A new natural history of Charcot foot: clinical evolution and final outcome of stage 0 Charcot neuroarthropathy in a tertiary referral diabetic foot clinic.
|
Clin Nucl Med
|
2013
|
0.77
|
|
17
|
Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamide.
|
Antivir Chem Chemother
|
2006
|
0.77
|
|
18
|
Proton magnetic resonance spectroscopy in the evaluation of patients with acute Charcot neuro-osteoarthropathy.
|
Eur Radiol
|
2013
|
0.76
|
|
19
|
Anti-gene peptide nucleic acid targeted to proviral HIV-1 DNA inhibits in vitro HIV-1 replication.
|
Antiviral Res
|
2005
|
0.75
|
|
20
|
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).
|
ChemMedChem
|
2006
|
0.75
|
|
21
|
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.
|
J Med Chem
|
2007
|
0.75
|
|
22
|
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
|
ChemMedChem
|
2006
|
0.75
|